Definitive Contract 75A50122C00017
Award Date 3/18/22
Potential Completion Date 5/30/26
Potential Value $5.3M
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Winston-Salem, NC 27101, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $998,790.43 federal contract award from the U.S. Army Medical Command (MEDCOM) to Keranetics, LLC, a small business. The contract is a Small Business Innovation Research (SBIR) Phase II award, which typically funds further development of technologies previously explored in a Phase I effort. The contract is a definitive contract with a completion date of November 5, 2019. The contract was set aside for small businesses. No additional details about the specific product or service being...
- This is a $1,070,532.90 firm fixed-price SBIR Phase II research and development contract awarded by the U.S. Army Medical Command (MEDCOM) to Keranetics Inc., a small business based in Winston-Salem, North Carolina. The contract is for the "Clinical Evaluation of Biocompatible Dressings for the Delivery of Analgesics" and was awarded under solicitation H2-0480. Keranetics is developing its KeraStat gel technology to prevent scar contracture after burn injuries. This SBIR Phase II...
- This is a firm-fixed-price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian federal agency, to Karius, Inc., a life sciences company based in Redwood City, California. The contract, valued at $630,976.00, is for research and development related to metagenomic sequencing of microbial cell-free DNA and RNA for comprehensive pathogen detection. This contract does not have a set-aside designation, indicating Karius competed as a...
- This is a $3,044,549.00 fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.). The contract is for biomedical research and development work, with a period of performance ending on March 31, 2010. No set-aside designations were used. Resilience Government Services, a technology-focused biomanufacturing company, has...
- This is a $1,999,961.00 Firm Fixed Price contract awarded by the National Cancer Institute (NCI) to Kephera Diagnostics LLC, a for-profit limited liability company. The contract was set aside for small businesses under the Small Business Innovation Research (SBIR) program. The contract is for the development of an in vitro diagnostic test for the liver flukes Opisthorchis viverrini and Clonorchis sinensis, with a period of performance through March 15, 2026. Kephera Diagnostics specializes in...
- This is a $10,299,171.18 cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Humanetics Corp, a for-profit biopharmaceutical company. The contract is for an NHP (non-human primate) efficacy study of BIO 300, a therapeutic candidate being developed by Humanetics to mitigate radiation-induced pneumonitis and pulmonary fibrosis. This work builds on Humanetics' prior federal grants from agencies like NIH, DoD, and the Army for research and...
- This is a $300,000.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Kephera Diagnostics LLC, a for-profit limited liability company. The contract is part of the SBIR 133 program, which does not have a set-aside designation. The contract focuses on advancing Kephera Diagnostics' research and development of innovative diagnostic solutions for infectious diseases, with a particular emphasis on neglected tropical...
- This is a prime contract award to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services. The $14,898,362.53 cost-plus-fixed-fee contract is for biomedical research and development. It has a period of performance through December 31, 2011 and does not have a set-aside designation. Resilience Government Services is a technology-focused...
- This is a $5,721,770.90 definitive, cost-plus-fixed-fee contract awarded by the Defense Health Agency (DHA) to Emergent Product Development Gaithersburg Inc., a for-profit manufacturer of medical countermeasures and pharmaceuticals. The contract is for the creation of an FDA-approved analgesic ketamine drug with an auto-injector delivery system. The award is not associated with a larger contract vehicle and does not have a set-aside designation. The contract has a period of performance through...
- This is a $1,299,857.19 firm fixed-price contract awarded by the Defense Health Agency (DHA) to Kericure Inc. for the development of deployable wound care products to decrease preventable death outcomes by mitigating infection on the battlefield and through long-term care. The contract is part of the Small Business Innovation Research (SBIR) program, designated as a total small business set-aside. Kericure Inc., a woman-owned small business, will conduct research and development related to...